Organized by the Multiple Myeloma Research Foundation (MMRF) & Sylvester Comprehensive Cancer Center, the meeting brought together leading experts in multiple myeloma who discussed the use of measurable residual disease (MRD) in clinical and trial settings, furthering our understanding of recent advances in the disease, and encouraged interactive discussion. VJHemOnc was official media partner of the meeting.

Miami Myeloma MRD 2021

13 October 2021 | Virtual Meeting

Miami Myeloma MRD 2021

13 October 2021 | Virtual Meeting
Organized by the Multiple Myeloma Research Foundation (MMRF) & Sylvester Comprehensive Cancer Center, the meeting brought together leading experts in multiple myeloma who discussed the use of measurable residual disease (MRD) in clinical and trial settings, furthering our understanding of recent advances in the disease, and encouraged interactive discussion. VJHemOnc was official media partner of the meeting.
Biology of MRD
Francesco Maura
Biology of MRD
Francesco Maura Sylvester Comprehensive Cancer Center, Miami, FL, United States
Next-Generation Sequencing
Lanny Kirsch
NGS-based MRD: applications in myeloma
Lanny Kirsch Adaptive Biotech, Seattle, WA, United States
Proteomics
Katie Thoren
Proteomics: MSKCC approach/Binding Site
Katie Thoren Memorial Sloan Kettering Cancer Center, New York City, NY, United States
Angela  Dispenzieri
Proteomics: Mayo Clinic approach
Angela Dispenzieri Mayo Clinic, Rochester, MN, United States
Liquid biopsies
Irene Ghobrial
Liquid biopsies: Dana-Farber Cancer Institute approach
Irene Ghobrial Dana-Farber Cancer Institute, Boston, MA, United States
Trevor Pugh
Liquid biopsies: UHN approach
Trevor Pugh University of Toronto, Ontario, Canada
David Coffey
Liquid biopsies: Sylvester Cancer Center approach
David Coffey Sylvester Comprehensive Cancer Center, Miami, FL, United States
Imaging
Gary Ulaner
Imaging: Immuno-PET
Gary Ulaner Hoag Family Cancer Institute, Irvine, CA, United States
Peter  Choyke
Imaging: the tumor and the micro-environment
Peter Choyke National Cancer Institute, Bethesda, MD, United States
New MRD technologies – panel discussion
Panel discussion on new MRD technologies
Discussion with FDA
Nicole Gormley
Fireside chat: FDA update of MRD for myeloma
Nicole Gormley Food and Drug Administration (FDA), Bethesda, MD, United States
Smoldering myeloma setting
Maria-Victoria Mateos
Smoldering myeloma: PETHEMA trial
Maria-Victoria Mateos University Hospital of Salamanca, Salamanca, Spain
Dickran Kazandjian
Smoldering myeloma: NCI trial
Dickran Kazandjian Sylvester Comprehensive Cancer Center, Miami, FL, United States
Newly-diagnosed multiple myeloma setting
Neha Korde
NDMM setting: Manhattan trial
Neha Korde Memorial Sloan Kettering Cancer Center, New York City, NY, United States
Stefania Oliva
NDMM setting: FORTE trial
Stefania Oliva University of Torino, Turin, Italy
Aurore Perrot
NDMM setting: IFM2009 update
Aurore Perrot University of Toulouse, Toulouse, France
Elisabet Manasanch
NDMM setting: New ADVANCE trial
Elisabet Manasanch The University of Texas MD Anderson Cancer Center, Afghanistan
Edward Chan
NDMM setting: MagnetisMM-1 trial
Edward Chan Pfizer Oncology, San Francisco, CA, United States
Maintenance setting
Benjamin Diamond
Maintenance setting: MSKCC long-term lenalidomide maintenance
Benjamin Diamond Sylvester Comprehensive Cancer Center, Miami, FL, United States
Current & future role of MRD in clinical trials – panel discussion
Panel Discussion: current and future role of MRD in clinical trials?
MRD in daily practice: today and tomorrow
Benjamin Derman
MRD in daily practice: UChicago perspective
Benjamin Derman University of Chicago Medical Center, Chicago, IL, United States
Nina  Shah
MRD in daily practice: UCSF experience
Nina Shah University of California, San Francisco, CA, United States
Rafael Fonseca
MRD in daily practice: Mayo Clinic experience
Rafael Fonseca Mayo Clinic, Phoenix, AZ, United States

This meeting was supported by the following sponsors:

Explore our dedicated Multiple Myeloma Channel and MRD Focus for the latest updates

Watch the Multiple Myeloma Channel

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter